KD Logo

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] stock was sold by MIGNONE ROBERTO at the price of US$8.84 million

In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Director MIGNONE ROBERTO unloaded Company’s shares for reported $8.84 million on Jun 18 ’24. In the deal valued at $17.03 per share,519,000 shares were sold. As a result of this transaction, MIGNONE ROBERTO now holds 981,000 shares worth roughly $16.35 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Weiss Amir sold 12,635 shares, generating $210,377 in total proceeds. Upon selling the shares at $16.65, the Chief Accounting Officer now owns 5,179 shares.

Before that, Weiss Amir sold 15,500 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $260,417 were divested by the Chief Accounting Officer at a price of $16.80 per share. As a result of the transaction, Weiss Amir now holds 17,814 shares, worth roughly $0.3 million.

Argus upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “an Underweight” to “a Neutral”. Piper Sandler also remained covering TEVA and has increased its forecast on February 12, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Jefferies revised its rating on January 23, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.

Price Performance Review of TEVA

On Monday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -2.51% to $16.67. Over the last five days, the stock has lost -1.83%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 59.67% since the year began. Nevertheless, the stocks have risen 97.98% over the past one year. While a 52-week high of $17.69 was reached on 06/12/24, a 52-week low of $8.06 was recorded on 01/02/24. SMA at 50 days reached $16.74, while 200 days put it at $12.98. A total of 7.76 million shares were traded, compared to the trading of 9.09 million shares in the previous session.

Levels Of Support And Resistance For TEVA Stock

The 24-hour chart illustrates a support level at 16.42, which if violated will result in even more drops to 16.17. On the upside, there is a resistance level at 17.00. A further resistance level may holdings at 17.32. The Relative Strength Index (RSI) on the 14-day chart is 49.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.35%. Stochastics%K at 61.52% indicates the stock is a holding.

Most Popular